CDEK
← All organizations

Savient Pharmaceuticals

For profitContributed to NME

Also known as: Savient Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2003

First marketed drug

Sep 14, 2010

First NDA

Sep 14, 2010

Last known activity

Dec 1, 2012

Acquired by Crealta → Horizon Pharma → Amgen on Jan 1, 2013

Timeline

1980s

  1. Jan 1, 1980

    Savient Pharmaceuticals— Founded

1990s

  1. Jan 1, 1993

    Gynex— Acquired

2010s

  1. Sep 14, 2010

    pegloticase— NDA Organization

  2. Jan 1, 2013

    Crealta— Acquired By

Drugs by trial phase (2 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (10)

Details

Founded
East Brunswick, NJ, US Jan 1, 1980
First NDA
Sep 14, 2010
Last known activity
Dec 1, 2012

Designations held

  • Orphan drug

Notes

Acquired by Crealta 11 Dec 2013